Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245242 · ClinicalTrials.gov registry record
Pediatric Urology Recovery After Surgery Endeavor (PURSUE)
A clinical trial of Urinary Bladder, Neurogenic and Urinary Bladder Diseases, sponsored by Washington University School of Medicine.
- Active
- Registry status
- 85
- Enrollment target
- 7
- Study locations
NCT03245242: Active study of Urinary Bladder, Neurogenic and Urinary Bladder Diseases, sponsored by Washington University School of Medicine.
NCT03245242 is a study of Urinary Bladder, Neurogenic and Urinary Bladder Diseases that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 85 participants, above the 59-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (44% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03245242, a study of Urinary Bladder, Neurogenic and Urinary Bladder Diseases, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 85 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this research study is to evaluate an Enhanced Recovery After Surgery (ERAS) protocol in children and young adults undergoing urologic reconstructive surgery. The investigators plan to collect data on speed of recovery (how quickly pain improves, length of time in the hospital, and the need for additional pain control) on patients who receive care under the ERAS protocol and compare it to historical controls.
Primary Outcome
Adherence to ERAS protocol items with # of items achieved (out of 20)
Conditions Studied
Interventions
- OTHER Enhanced Recovery after Surgery
- OTHER Historical usual surgical care
Study Locations (7)
Colorado
- Children's Hospital Colorado - Aurora
Illinois
- Ann & Robert Lurie Children's Hospital of Chicago - Chicago
Missouri
- Washington University School of Medicine - St Louis
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Oklahoma
- Oklahoma University Health Science Center - Oklahoma City
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Virginia
- Children's Hospital of Richmond at Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2026-10-31 |
What the registry record for NCT03245242 still lists
NCT03245242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target, above the 59-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (44% higher).
The record links to 3 conditions, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Recovery after Surgery is the first listed.
NCT03245242 lists 7 locations in 7 states (Colorado, Illinois, Missouri).
Frequently Asked Questions
What is clinical trial NCT03245242 about?
NCT03245242 is a clinical study titled "Pediatric Urology Recovery After Surgery Endeavor (PURSUE)". The purpose of this research study is to evaluate an Enhanced Recovery After Surgery (ERAS) protocol in children and young adults undergoing urologic reconstructive surgery. The investigators plan to collect data on speed of recovery (how quickly pain improves, length of time in the hospital, and th...
What is the current status of trial NCT03245242?
This trial is currently active not recruiting. The enrollment target is 85 participants. The study started on 2017-04-01. Estimated completion is 2026-10-31.
What conditions does trial NCT03245242 study?
This clinical trial studies the following conditions: Urinary Bladder, Neurogenic, Urinary Bladder Diseases, Urologic Surgical Procedures.
What interventions are being tested in trial NCT03245242?
The interventions under investigation include: Enhanced Recovery after Surgery (OTHER), Historical usual surgical care (OTHER).
Who is sponsoring clinical trial NCT03245242?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03245242 being conducted?
This trial has 7 study locations across Colorado, Illinois, Missouri, Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Bladder, Neurogenic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
RECRUITING · NA
-
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
RECRUITING
-
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
RECRUITING · NA
-
Cystoealstometer (Bladder Monitor Device)-Home Use
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI